Bradley Merrill Thompson Quoted in Multiple Publications Regarding the 21st Century Cures ActMultiple Publications April 30, 2015
Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in multiple publications regarding the 21st Century Cures Act.
Following is an excerpt from Politico:
… Bradley Merrill Thompson of the CDS Coalition disagreed — he said it’s more complicated now: “The new draft of the legislation does away with the idea of creating a separate category of FDA-regulated software to get special treatment. Instead, the new draft would direct FDA to come up with a new approach for regulating any kind of software the agency regulates. That’s a worthwhile change.”
BNA Snapshot, 4/29/2015